Explore our comprehensive coverage of psychedelic therapy, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's approval of MDMA-assisted therapy, the WHO's AI chatbot oversight, and the EU's corporate psychological mandates have fundamentally rewritte...
Read Full Story →
Mental HealthThe FDA’s approval of consumer at-home neuromodulation devices, coupled with the DEA’s reclassif...
Mental HealthThe psychiatric care infrastructure is undergoing a structural reset driven by federal psychedelic c...
Mental HealthThe mental health sector is undergoing a severe structural reset as autonomous AI therapeutics, psyc...
Mental HealthThe convergence of FDA psychedelic protocols, algorithmic friction mandates, and biometric fatigue t...
Mental HealthThe simultaneous implementation of the EU’s Cognitive Liberty Act, mandatory athlete biometric mon...
Mental HealthThe convergence of FDA regulatory friction, corporate EAP failures, and biometric wearables is funda...
